Liquidia (FRA:LT4) Change In Inventory : €-0.40 Mil (TTM As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Liquidia Change In Inventory?

Liquidia's change in inventory for the quarter that ended in Dec. 2024 was €-0.19 Mil. It means Liquidia's inventory increased by €0.19 Mil from Sep. 2024 to Dec. 2024 .

Liquidia's change in inventory for the fiscal year that ended in Dec. 2024 was €-0.23 Mil. It means Liquidia's inventory increased by €0.23 Mil from Dec. 2023 to Dec. 2024 .

Liquidia's Total Inventories for the quarter that ended in Dec. 2024 was €0.23 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Liquidia's Days Inventory for the quarter that ended in Dec. 2024 was 9.32.

Inventory Turnover measures how fast the company turns over its inventory within a year. Liquidia's Inventory Turnover for the quarter that ended in Dec. 2024 was 9.80.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Liquidia's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.05.

Liquidia Change In Inventory Historical Data

The historical data trend for Liquidia's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Liquidia Change In Inventory Chart

Liquidia Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

Get a 7-Day Free Trial

-0.23

Liquidia Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Inventory	Get a 7-Day Free Trial															-	-3.24	-3.43	6.46	-0.19

Liquidia Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.40 Mil.

Liquidia (FRA:LT4) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Liquidia's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0.132	/	1.293	*	365 / 4
	=	9.32

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Liquidia's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	1.293	/	0.132
	=	9.80

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Liquidia's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.132	/	2.786
	=	0.05

Liquidia Change In Inventory Related Terms

Thank you for viewing the detailed overview of Liquidia's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Liquidia Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Liquidia Corp (FRA:LT4) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

LQDA:USA

Address

419 Davis Drive, Suite 100, Morrisville, NC, USA, 27560

Website

https://www.liquidia.com

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Liquidia Headlines

No Headlines